Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 21.37 CNY 0.33% Market Closed
Market Cap: 60.9B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 46.9 CNY. Compared to the current market price of 21.37 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 54%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
46.9 CNY
Undervaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Shanghai Pharmaceuticals Holding Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Shanghai Pharmaceuticals Holding Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Shanghai Pharmaceuticals Holding Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Shanghai Pharmaceuticals Holding Co Ltd

Provide an overview of the primary business activities
of Shanghai Pharmaceuticals Holding Co Ltd.

What unique competitive advantages
does Shanghai Pharmaceuticals Holding Co Ltd hold over its rivals?

What risks and challenges
does Shanghai Pharmaceuticals Holding Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide P/S
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide P/E
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide P/OCF
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide P/FCFE
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide P/B
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/S
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/GP
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/EBITDA
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/EBIT
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/OCF
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/FCFF
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide EV/IC
for Shanghai Pharmaceuticals Holding Co Ltd.

Show me price targets
for Shanghai Pharmaceuticals Holding Co Ltd made by professional analysts.

What are the Revenue projections
for Shanghai Pharmaceuticals Holding Co Ltd?

How accurate were the past Revenue estimates
for Shanghai Pharmaceuticals Holding Co Ltd?

What are the Net Income projections
for Shanghai Pharmaceuticals Holding Co Ltd?

How accurate were the past Net Income estimates
for Shanghai Pharmaceuticals Holding Co Ltd?

What are the EPS projections
for Shanghai Pharmaceuticals Holding Co Ltd?

How accurate were the past EPS estimates
for Shanghai Pharmaceuticals Holding Co Ltd?

What are the EBIT projections
for Shanghai Pharmaceuticals Holding Co Ltd?

How accurate were the past EBIT estimates
for Shanghai Pharmaceuticals Holding Co Ltd?

Compare the revenue forecasts
for Shanghai Pharmaceuticals Holding Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shanghai Pharmaceuticals Holding Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shanghai Pharmaceuticals Holding Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shanghai Pharmaceuticals Holding Co Ltd compared to its peers.

Compare the P/E ratios
of Shanghai Pharmaceuticals Holding Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shanghai Pharmaceuticals Holding Co Ltd with its peers.

Analyze the financial leverage
of Shanghai Pharmaceuticals Holding Co Ltd compared to its main competitors.

Show all profitability ratios
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide ROE
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide ROA
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide ROIC
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide ROCE
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Gross Margin
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Operating Margin
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Net Margin
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide FCF Margin
for Shanghai Pharmaceuticals Holding Co Ltd.

Show all solvency ratios
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide D/E Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide D/A Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Interest Coverage Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Altman Z-Score Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Quick Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Current Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

Provide Cash Ratio
for Shanghai Pharmaceuticals Holding Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shanghai Pharmaceuticals Holding Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shanghai Pharmaceuticals Holding Co Ltd?

What is the current Free Cash Flow
of Shanghai Pharmaceuticals Holding Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shanghai Pharmaceuticals Holding Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd

Current Assets 162.4B
Cash & Short-Term Investments 38.7B
Receivables 81.9B
Other Current Assets 41.8B
Non-Current Assets 49.5B
Long-Term Investments 10.9B
PP&E 18.3B
Intangibles 17.8B
Other Non-Current Assets 2.6B
Current Liabilities 122.4B
Accounts Payable 47.9B
Accrued Liabilities 10.9B
Short-Term Debt 51.6B
Other Current Liabilities 11.9B
Non-Current Liabilities 21.1B
Long-Term Debt 7.3B
Other Non-Current Liabilities 13.7B
Efficiency

Earnings Waterfall
Shanghai Pharmaceuticals Holding Co Ltd

Revenue
272.4B CNY
Cost of Revenue
-242.7B CNY
Gross Profit
29.8B CNY
Operating Expenses
-21.3B CNY
Operating Income
8.5B CNY
Other Expenses
-4.4B CNY
Net Income
4B CNY

Free Cash Flow Analysis
Shanghai Pharmaceuticals Holding Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Positive Gross Profit
47/100
Profitability
Score

Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
52/100
Solvency
Score

Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd

Wall Street analysts forecast Shanghai Pharmaceuticals Holding Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 21.87 CNY with a low forecast of 13.74 CNY and a high forecast of 26.15 CNY.

Lowest
Price Target
13.74 CNY
36% Downside
Average
Price Target
21.87 CNY
2% Upside
Highest
Price Target
26.15 CNY
22% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shanghai Pharmaceuticals Holding Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shanghai Pharmaceuticals Holding Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd

Country

China

Industry

Health Care

Market Cap

60.9B CNY

Dividend Yield

0%

Description

Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 47,056 full-time employees. Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The firm's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The firm's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The firm distributes its products both in the domestic market and to overseas markets.

Contact

SHANGHAI
Shanghai
Shanghai Pharmaceutical Mansion, No.200 Taicang Road
+862163730908.0
www.sphchina.com

IPO

1994-03-24 00:00:00

Employees

47 056

Officers

Executive Chairman
Mr. Qiuhua Yang
President, CFO, Head of the Accounting Department & Executive Director
Mr. Bo Shen CPA
VP & Executive Director
Mr. Yongzhong Li
Executive Director
Mr. Ming Dong
VP, Board Secretary & Joint Company Secretary
Mr. Tao Zhong
Vice President
Ms. Shuai Shao
Show More
Chief Medical Officer
Dr. Shunjiang Yu
Joint Company Secretary
Ms. Pui Kiu Wong
Director & General Manager of R&D Management Center
Ying Ke
Show Less

See Also

Discover More
What is the Intrinsic Value of one Shanghai Pharmaceuticals Holding Co Ltd stock?

The intrinsic value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 46.9 CNY.

Is Shanghai Pharmaceuticals Holding Co Ltd stock undervalued or overvalued?

Compared to the current market price of 21.37 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 54%.

Back to Top